| Authors: |
Asogwa OA; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Walbert T; Department of Neurology and Neurosurgery, Henry Ford Health System, Wayne State University and Michigan State University, Detroit, Michigan, USA., Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Arons D; National Brain Tumor Society, Newton, Massachusetts, USA., van den Bent MJ; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Blakeley J; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Coomans MB; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Brown PD; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA., Bulbeck H; Brainstrust-The Brain Cancer People, Cowes, Isle of Wight, UK., Chang SM; Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, California, USA and UCSF Brain Tumor Center, University of California, San Francisco, California, USA., Coens C; Statistical Department, European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Grant R; Department of Clinical Neurosciences, Royal Infirmary of Edinburgh, Edinburgh, UK., Jalali R; Neuro-Oncology Cancer Management Team, Apollo Proton Cancer Centre, Chennai, India., Koekkoek JAF; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Panda PK; Clinical Research Secretariat, Apollo Proton Cancer Centre, Chennai, India., Leach D; National Brain Tumor Society, Newton, Massachusetts, USA., Leeper H; Department of Neurology and Department of Medicine, Section of Geriatrics and Palliative Medicine, University of Chicago, Chicago, Illinois, USA., Mendoza T; Office of Patient-Centered Outcomes Research, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Oliver K; International Brain Tumour Alliance, Tadworth, Surrey, UK., Reijneveld JC; Department of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.; Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Le Rhun E; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Rubinstein L; Biometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Taylor JW; Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, California, USA and UCSF Brain Tumor Center, University of California, San Francisco, California, USA., Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. |
